MedPath

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Phase 3
Recruiting
Conditions
Nasopharyngeal Carcinoma
Quality of Life
Bacterial Colonization
Radiation-induced Oral Mucositis
Interventions
Registration Number
NCT05893810
Lead Sponsor
Jiangxi Provincial Cancer Hospital
Brief Summary

The purpose of this study is to determine whether bacterial decolonization of the nares prior to treatment with radiotherapy (RT) for patients with nasopharyngeal carcinoma, can prevent high-grade radiation-induced oral mucositis (RIOM) and improve quality of life.

This study is being conducted because a randomized clinical trials form Yana Kost et al. have found bacterial decolonization in the nose prior to initiation of RT was effective for prevention of acute radiation dermatitis.

Patients in the treatment arm will receive pretreatment with mupirocin ointment to the nares while patients in the control arm will receive standard of care treatment. Bacterial cultures will be taken from the nares and mouth, and participants will also complete a quality of life questionnaire before and after RT.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
176
Inclusion Criteria
  1. Patients with newly histologically confirmed nasopharyngeal carcinoma
  2. No evidence of distant metastasis (M0)
  3. ECOG (Eastern Cooperative OncologyGroup) scale 0-1
  4. 18-70 years old
Exclusion Criteria
  1. Previous or existing mental or cognitive impairment;
  2. Patients with other malignant tumors at the same time;
  3. Have received bacterial decolonization therapy;
  4. Oral mucositis or ulcers existed before radiotherapy.
  5. Prior RT to the region of interest

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment ArmMupirocin OintmentThe purpose of this study is to determine whether bacterial decolonization of the nares prior to treatment with radiotherapy (RT) for patients with nasopharyngeal carcinoma, can prevent radiation-induced oral mucositis(RIOM) and improve quality of life.
Primary Outcome Measures
NameTimeMethod
High-grade radiation-induced oral mucositisradiation-induced oral mucositis(graded by the RTOG) will be assessed at the last treatment session (study week depends on patient's length of treatment, but ranges from 6 weeks to 8 weeks)

Grade 3 or higher radiation-induced oral mucositis according to RTOG

Secondary Outcome Measures
NameTimeMethod
High-grade radiation dermatitisRadiation dermatitis (graded by the CTCAE) will be assessed at the last treatment session (study week depends on patient's length of treatment, but ranges from 6 weeks to 8 weeks)

Grade 3 or higher radiation-induced dermatitis according to RTOG

Quality of Life according QLQ-H&N43Quality of Life (according QLQ-H&N43) will be assessed at the last treatment session (study week depends on patient's length of treatment, but ranges from 6 weeks to 8 weeks)

EORTC QLQ-H\&N43

Trial Locations

Locations (1)

Jiangxi Cancer Hospital

🇨🇳

Nanchang, Jiangxi, China

© Copyright 2025. All Rights Reserved by MedPath